CONTACT US
Life Science Molecule life sciences molecules

NEW JERSEY LIFE SCIENCES + TECH ADVISORS

New Jersey, often referred to as “The Nation’s Medicine Chest”, is home to more than 3,200 life science and biopharma establishments, including 14 of the world’s top 20 pharmaceutical companies. Located in the densely populated and transit-connect Northeast Corridor, New Jersey’s robust pharma legacy thrives due to industry leaders such as Merck, Johnson & Johnson, Bristol Myers Squibb, Novartis, and Pfizer attracting a highly educated workforce. The state boasts the second-highest concentration of scientists and engineers in the U.S., and ranks third in employment of biochemists and biophysicists. Additionally, New Jersey offers ample second-generation lab space, providing an ideal environment for emerging bio-tech companies to flourish.

Cushman & Wakefield’s New Jersey Life Sciences & Tech Advisory team consists of local experts in the life sciences market. Our extensive global experience allow us to approach transactions with creativity and agility, ensuring a seamless process that saves time and reduces expenses. We specialize in aligning real estate strategies to business objectives, leveraging a profound understanding of labor markets, tax incentives, market dynamics, and the complexities of constructing specialized facilities.

The New Jersey Life Sciences & Tech Advisory team is a member of Cushman & Wakefield's National Life Sciences Practice Group. This globally diverse network delivers integrated solutions to investors, developers, and occupiers of life sciences real estate. Strategically positioned in major life sciences hub markets across the country, our experienced teams offer comprehensive coverage where innovation thrives. We build global connections, foster a culture of collaboration, and leverage cutting-edge data and research to meet our clients’ ever-evolving needs, wherever they want to be. With expertise in all areas of life sciences real estate, from site selection and lease negotiation to property and project management, we proudly partner with our clients in their mission to make the world a better place.

 

 

Meet the Advisory Team

Todd Elfand New Jersey
Todd Elfand

Executive Managing Director
Iselin, United States


+1 (732) 452-6187 x356187

Download VCard

Charles Parmelli New Jersey Leasing
Charles Parmelli

Executive Managing Director
Morristown, United States


+1 (973) 908-6105

Download VCard

Shawn Straka Morristown
Shawn Straka

Executive Director
Morristown, United States


+1 (973) 292-4603 x354603

Download VCard

Meet the PDS Team

Jason D'Orlando (image)
Jason D'Orlando

Executive Managing Director, Project & Development Services
Raleigh, United States


Download VCard

kevin Camponeschi
Kevin Camponeschi

MD, Project & Development Services
Baltimore, United States


Download VCard

Meet the V & A Team

Rob Maloney
Robert Maloney

Executive Director
Boston, United States


+1 (617) 204-4121

Download VCard

Meet the Capital Markets Team

David Bernhaut New Jersey Executive Vice Chairman
David Bernhaut

Executive Vice Chairman
East Rutherford, United States


+1 (201) 460-3356

Download VCard

Meet Our Other Team Members

rachel park
Rachel Park

Consulting Director, Total Workplace
New York, United States


+1 (646) 8231744

Download VCard

Jane Orlin Stamford Business Incentives
Jane Orlin

Executive Managing Director
Tampa, United States


+1 (203) 326-5878

Download VCard

Recent Tenant Advisory Transactions

2 Clarke Drive 750x456 - New Jersey Life Sciences and Tech Advisory.png
2 Clarke Drive

Property Address: 2 Clarke Drive, Cranbury, NJ
Size: 72,000 SF
CMIC 750x456 - New Jersey Life Sciences and Tech Advisory.jpg
270 Prospect Plains Road

Property Address: 270 Prospect Plains Road, Cranbury, NJ
Size: 223,936 SF
Client: CMIC
311 Pennington Rocky Hill Road - PTC Therapeutics - 750x456 - New Jersey Life Sciences and Tech Advisory.png
311 Pennington Rocky Hill Road

Property Address: 311 Pennington Rocky Hill Road, Hopewell Township, NJ
Size: 223,000 SF
Client: PTC Therapeutics

Related Insights

life sciences
Research

Life Sciences Update

The life sciences industry enters 2024 with measured optimism, signaling that the sector has reverted to its long-term trend for growth. A flurry of recent announcements, from strong initial public offerings to exciting new mergers and acquisitions, has breathed new life into the industry.
Sandy Romero • 3/6/2024
life sciences funding in view
Research

​​Life Sciences Funding in View​

Global life sciences venture capital funding has reverted to its pre-pandemic long-term trend.
Sandy Romero • 1/29/2024
life sciences
Research

​​Recent Ups and Downs for the Life Sciences Market​

​Life sciences tenants searching for space is up over 22% since late spring with activity in real estate grew as well, with over 31 million square feet (sf) of lab and cGMP space leased from 2021 to 2022.
Sandy Romero • 11/8/2023
life science lab
Research

Life Sciences Fit Out Cost Guide

Our Life Sciences Fit Out Cost Guide covers nine lab and cGMP facility types across the six major U.S. life sciences markets.
Sandy Romero • 9/7/2023
LifeSciences-Checklist_card
Article

Does your building qualify for a life sciences conversion?

Interest in converting assets for life sciences use is growing amongst building owners. Cushman & Wakefield’s Project & Development Services team developed basic building performance criteria based on the minimum standards that life sciences companies typically require. 
Eric Giles • 7/18/2023
Life Science
Article

Challenges for Life Sciences Projects Means Early Engagement of Project Managers

Persistent challenges continue to impact costs, material lead times and project timelines across all life sciences projects.
Jason D'Orlando • 6/30/2023

Ready to talk?

Get in touch and we can help with any additional information you need.

With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on  Cookies

More Options
Agree and Close
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All
SAVE SETTINGS